Inventor · disambiguated record
Jaroslaw Mazurek
Also filed as: MAZUREK JAROSLAW · MAZUREK JAROSLAW MAREK
2 granted patents·5 pending applications·11 citations·filing 2007–2014
50Inventor score
Files withULTIMORPHIX TECHNOLOGIES B V2AMPARO EUGENE C1BOEHRINGER INGELHEIM INT1BOEHRINGER INGELHEIM PHARMA1MAZUREK JAROSLAW1
Top patents by PatentIndex Score
7 records- 0175US8541391B2Crystalline phases of 5,6-dichloro-2-(isopropylamino)-1-β-L-ribofuranosyl-1H-benzimidazoleAMPARO EUGENE C·Filed 2011·Granted Sep 24, 2013·11 cites·13 claims
- 0251US2012322810A9New saltsMAZUREK JAROSLAW·Filed 2009·Application pending·0 cites
- 0346US9546141B2SaltsSPROUT PHARMACEUTICALS INC·Filed 2014·Granted Jan 17, 2017·0 cites·8 claims
- 0445US2009176983A1Tenofovir Disoproxil Hemi-Fumaric Acid Co-CrystalULTIMORPHIX TECHNOLOGIES B V·Filed 2008·Application pending·0 cites
- 0544US2009318471A1New Salts and Crystalline Salt Forms of an Indolinone DerivativeBOEHRINGER INGELHEIM INT·Filed 2007·Application pending·0 cites
- 0642US2009270352A1Tenofovir Disoproxil Hemi-Fumaric Acid Co-CrystalULTIMORPHIX TECHNOLOGIES B V·Filed 2008·Application pending·0 cites
- 0742US2010144796A1New polymorphs of ethyl 3-[(2-{[4-(hexyloxycarbonylamino-imino- methyl)-phenylamino]-methyl-1-methyl-1h-benzimidazole-5-carbonyl) -pyridin-2-yl-amino]-propionateBOEHRINGER INGELHEIM PHARMA·Filed 2007·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Jaroslaw Mazurek files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →